Phase III trials of Sputnik V critical to know safety and efficacy: Lalit Kant
(WorldNews Health)

Covid-19 pandemic is spreading globally like a wild fire in dry leaves. Vaccine offers the only hope for its containment and prevention. So far, millions of dollars have been invested in fast tracking the development of vaccines and telescoping the duration of clinical trials from years to months. While the top pharma companies across the world are hopeful to come up with a vaccine by the year end, Russia in August announced the launch of Sputnik V, its home brewed adenovirus-based vaccine candidate against covid-19, for the citizens. India too has decided to take the Russian vaccine after clinical trials on Indians. Lalit Kant, Infectious Disease Epidemiologist and former head of...